
Deborah Toppmeyer, MD
Advertisement
Articles by Deborah Toppmeyer, MD


ACR Appropriateness Criteria® Ductal Carcinoma in Situ
BySeth A. Kaufman, MD,Eleanor E. R. Harris, MD,Lisa Bailey, MD,Manjeet Chadha, MD,Sharon C. Dutton, MD,Gary M. Freedman, MD,Sharad Goyal, MD,Michele Y. Halyard, MD,Kathleen C. Horst, MD,Kristina L. M. Novick, MD,Catherine C. Park, MD,W. Warren Suh, MD,Deborah Toppmeyer, MD,Jennifer Zook, MD,Bruce G. Haffty, MD
Management of ductal carcinoma in situ (DCIS) commonly involves excision, radiotherapy, and hormonal therapy. Radiotherapy is employed for local control in breast conservation. Evidence is evolving for several radiotherapy techniques exist beyond standard whole-breast irradiation.

Management recommendations for breast cancer local-regional recurrence (LRR), including patient scenarios, are reviewed, and represent evidence-based data and expert opinion of the American College of Radiology Appropriateness Criteria Expert Panel on LRR.
Advertisement
Latest Updated Articles
ACR Appropriateness Criteria® Local-Regional Recurrence (LRR) and Salvage Surgery-Breast CancerPublished: February 15th 2014 | Updated:
ACR Appropriateness Criteria® Ductal Carcinoma in SituPublished: June 15th 2015 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Radiotherapy Dose Escalation Did Not Improve Efficacy/QOL in Anal Cancer
2
FDA Receives BLA for Ivonescimab Combo in Advanced/Metastatic EGFR+ NSCLC
3
FDA Issues New CRL for Tabelecleucel in Epstein Barr Virus–Positive PTLD
4
Atezolizumab Combo Does Not Significantly Boost Survival in Ovarian Cancer
5
